India's CRDMO sector, projected to hit $22-25 billion by 2035, is rapidly expanding due to cost advantages and quick startup ...

In an international collaboration, researchers have made an important breakthrough in the therapeutic delivery of microRNAs ...

This surge is also being driven by India's cost advantages compared to Western countries, 90 per cent faster project startup ...

Dr. Drew Weissman warns that a rise in anti-vaxxers could lead to deaths from preventable diseases like measles and polio, ...

India holds a two to three per cent share of the USD 140-145 billion global CRDMO market but has the potential to become a global leader.

A GROUNDBREAKING cancer vaccine reversed the disease in nine patients, a study has shown. They remained disease free three ...

The Indian Contract Research, Development, and Manufacturing Organization (CRDMO) sector is at an inflection point, with the potential to grow to $22 - $25 billion by 2035, according to a new report, ...

Our Bureau, Bengaluru Tuesday, February 25, 2025, 15:15 Hrs [IST] ...

The scientists demonstrate that it is possible to specifically deliver the treatment to the muscle stem cells, avoiding ...

India's CRDMO sector is set to reach USD 22-25 billion by 2035, driven by cost advantages and rapid project startups, according to a BCG and IPSO report. India is emerging as a preferred outsourcing ...

As part of this partnership, Lucence’s molecular testing solutions will be incorporated into Agilus’ oncology diagnostics ...

Through this collaboration, Agilus Diagnostics will integrate Lucence’s molecular testing solutions into its oncology ...